CCI
EW icon

Columbus Circle Investors’s Edwards Lifesciences EW Stock Holding History

Columbus Circle Investors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-51,000
Closed -$1.86M – 208
2017
Q3 		$1.86M Buy
+51,000
New +$1.95M 0.03% 229

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Columbus Circle Investors's EW Position: Q4 2020 in Review

Columbus Circle Investors sold out of Edwards Lifesciences (EW) in Q4 2020, closing a stake of 27,300 shares — an estimated $2.18M sold.

Columbus Circle Investors first reported a position in EW in Q3 2014 and held it in 20 quarters. The position peaked at $242M in Q3 2016. 1,158 funds tracked by Wall St. Rank hold EW as of Q4 2020.

  • Columbus Circle Investors reported no remaining Edwards Lifesciences position as of Q4 2020 after selling out during the quarter.
  • Columbus Circle Investors sold 27,300 Edwards Lifesciences shares in Q4 2020, an estimated $2.18M.
  • Columbus Circle Investors first reported a position in Edwards Lifesciences in Q3 2014 and held it in 20 quarters.
  • Columbus Circle Investors's Edwards Lifesciences position peaked at $242M in Q3 2016.
  • 1,158 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2020.

Based on Columbus Circle Investors's 13F filing for Q4 2020, filed 20 Jan 2021.